Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy, Safety, and Tolerability of TC-5619 in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
This study has been completed.
Study NCT01124708   Information provided by Targacept Inc.

First Received on May 5, 2010.   Last Updated on October 28, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
ADHD
Additional conditions recognized in this trial
Attention Deficit Disorder with Hyperactivity
Hyperkinesis
More general conditions related to this trial
Attention Deficit and Disruptive Behavior Disorders
Dyskinesias
Mental Disorders
Mental Disorders Diagnosed in Childhood
Nervous System Diseases
Neurologic Manifestations
Signs and Symptoms
Interventions listed in this trial
TC-5619-238
Placebo
Sponsors listed in this trial
Targacept Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services